| Schedule of Earnings Per Share |
The following table sets forth the computation
of the Company’s basic and diluted net income (loss) per share for each of the three and nine months ended September 30,
2019 and 2018:
| |
|
Three Months Ended
September 30,
|
|
|
Nine Months Ended
September 30,
|
|
| |
|
2019 |
|
|
2018 |
|
|
2019 |
|
|
2018 |
|
| Numerator: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net (loss) income from continuing operations |
|
$ |
(12,127,692 |
) |
|
$ |
97,356,081 |
|
|
$ |
(38,340,063 |
) |
|
$ |
(3,965,798 |
) |
| Net (loss) income from discontinued operations |
|
|
(138,076 |
) |
|
|
(159,430 |
) |
|
|
(791,936 |
) |
|
|
115,787 |
|
| Deemed dividends |
|
|
— |
|
|
|
(17,942,578 |
) |
|
|
(123,861,587 |
) |
|
|
(17,942,578 |
) |
| Net loss (income) to common shareholders -basic |
|
$ |
(12,265,768 |
) |
|
$ |
79,254,073 |
|
|
$ |
(162,993,586 |
) |
|
$ |
(21,792,589 |
) |
| Adjustments for diluted calculations: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Deduct change in fair value of derivative liabilities |
|
|
— |
|
|
|
(109,305,331 |
) |
|
|
— |
|
|
|
— |
|
| Amortize discounts associated with conversion of dilutive convertible debentures |
|
|
— |
|
|
|
(7,303,912 |
) |
|
|
— |
|
|
|
— |
|
| Remove change in warrant value for diluted |
|
|
— |
|
|
|
(11,376 |
) |
|
|
— |
|
|
|
— |
|
| Add back deemed dividends |
|
|
— |
|
|
|
17,942,578 |
|
|
|
— |
|
|
|
— |
|
| Net loss to common shareholders - diluted |
|
$ |
(12,265,768 |
) |
|
$ |
(19,423,968 |
) |
|
$ |
(162,993,586 |
) |
|
$ |
(21,792,589 |
) |
| Denominator: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Weighted average number of common shares outstanding during the period: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Basic |
|
|
6,634,045,471 |
|
|
|
5,531,767 |
|
|
|
4,461,922,587 |
|
|
|
2,550,632 |
|
| Common stock equivalents: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants |
|
|
— |
|
|
|
64,315,740 |
|
|
|
— |
|
|
|
— |
|
| Convertible preferred stock |
|
|
— |
|
|
|
9,505,156 |
|
|
|
— |
|
|
|
— |
|
| Convertible debentures |
|
|
— |
|
|
|
175,301,554 |
|
|
|
— |
|
|
|
— |
|
| Diluted |
|
|
6,634,045,471 |
|
|
|
254,654,217 |
|
|
|
4,461,922,587 |
|
|
|
2,550,632 |
|
| Net (loss) income per common share- continuing operations: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Basic |
|
$ |
(0.00 |
) |
|
$ |
17.60 |
|
|
$ |
(0.01 |
) |
|
$ |
(1.55 |
) |
| Diluted |
|
$ |
(0.00 |
) |
|
$ |
(0.08 |
) |
|
$ |
(0.01 |
) |
|
$ |
(1.55 |
) |
| Net (loss) income per common share- discontinued operations: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Basic |
|
$ |
(0.00 |
) |
|
$ |
(0.03 |
) |
|
$ |
(0.00 |
) |
|
$ |
0.05 |
|
| Diluted |
|
$ |
(0.00 |
) |
|
$ |
(0.00 |
) |
|
$ |
(0.00 |
) |
|
$ |
0.05 |
|
| Total per share net (loss) income to common shareholders: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Basic |
|
$ |
(0.00 |
) |
|
$ |
14.33 |
|
|
$ |
(0.04 |
) |
|
$ |
(8.54 |
) |
| Diluted |
|
$ |
(0.00 |
) |
|
$ |
(0.08 |
) |
|
$ |
(0.04 |
) |
|
$ |
(8.54 |
) |
|
| Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share |
Diluted loss per share as reflected in the
table above excludes all dilutive potential shares if their effect is anti-dilutive. For the nine months ended September 30, 2019
and 2018, the following table sets forth the computation of the following potential common stock equivalents excluded from the
calculation of diluted loss per share as their effect was anti-dilutive:
| |
|
Nine Months Ended September 30, |
|
| |
|
2019 |
|
|
2018 |
|
| Warrants |
|
|
634,525,355,377 |
|
|
|
463,449,767 |
|
| Convertible preferred stock |
|
|
82,901,785,590 |
|
|
|
68,344,495 |
|
| Convertible debentures |
|
|
30,634,784,339 |
|
|
|
214,222,495 |
|
| Stock options |
|
|
77 |
|
|
|
77 |
|
| |
|
|
748,061,925,383 |
|
|
|
746,016,834 |
|
|